<?xml version="1.0" encoding="UTF-8"?>
<ref id="hep41480-bib-0071">
 <label>71</label>
 <mixed-citation publication-type="journal" id="hep41480-cit-0071">
  <string-name>
   <surname>
    <bold>Wedemeyer</bold>
   </surname>
   <given-names>H</given-names>
  </string-name>, 
  <string-name>
   <surname>
    <bold>Yurdaydìn</bold>
   </surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Dalekos</surname>
   <given-names>GN</given-names>
  </string-name>, 
  <string-name>
   <surname>Erhardt</surname>
   <given-names>A</given-names>
  </string-name>, 
  <string-name>
   <surname>Çakaloğlu</surname>
   <given-names>Y</given-names>
  </string-name>, 
  <string-name>
   <surname>Değertekin</surname>
   <given-names>H</given-names>
  </string-name>, et al. 
  <article-title>Peginterferon plus adefovir versus either drug alone for hepatitis delta</article-title>. 
  <source xml:lang="en">N Engl J Med</source>
  <year>2011</year>;
  <volume>364</volume>:
  <fpage>322</fpage>‐
  <lpage>331</lpage>.
  <pub-id pub-id-type="pmid">21268724</pub-id>
 </mixed-citation>
</ref>
